Drug Trial Radar · NCT06875973
Pelacarsen Roll-over Extension Program
Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
599
Planned (sponsor's estimate)
Start
May 19, 2025
Primary completion
Dec 8, 2030
Study completion Dec 8, 2030
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Mar 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This non-randomized, rollover extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed either of the double-blind parent studies (CTQJ230A12303 or CTQJ230A12304). Study has been terminated by sponsor following the outcome of the Lp(a)HORIZON study (NCT04023552), which did not meet its primary endpoint.
Conditions
- Atherosclerotic Cardiovascular Disease
Interventions
Pelacarsen (TQJ230)Drug
pelacarsen 80mg s.c. monthly
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Adverse events (AEs) or serious adverse events (SAEs)Time frame: Up to 48 months
Locations
89 sites in 2 countries. Site status is shown where the registry gives one.
Parkway Medical Center
Birmingham, Alabama
Cardiology and Medicine Clinic PA
Little Rock, Arkansas
National Heart Institute
Beverly Hills, California
Hope Clinical Research
Canoga Park, California
Valley Clinical Trials Inc
Covina, California
NICRs Research Center
Garden Grove, California
University of Calif Irvine Med Cntr
Irvine, California
Long Beach Clinical Trials
Long Beach, California
Angel City Research Inc
Los Angeles, California
California Medical Research Associates Inc
Northridge, California
Stanford Health Care
Stanford, California
Excel Medical Clinical Trials LLC
Boca Raton, Florida
C and A Clinical Trials
Cape Coral, Florida
Proactive Clinical Research
Fort Lauderdale, Florida
National Research Institute
Hialeah, Florida
Sister Life Research Inc
Hialeah, Florida
Zenith Clinical Research
Hollywood, Florida
Columbus Clinical Services LLC
Miami, Florida
Finlay Medical Research
Miami, Florida
Infinite Clinical Research
Miami, Florida
International Research Associates LLC
Miami, Florida
Baptist Health South
Miami, Florida
A&A Research Group Inc
Miami, Florida
Inpatient Research Clinical LLC
Miami Lakes, Florida
FXM Clin Res Miramar LLC
Miramar, Florida
CTMD Research
Palm Springs, Florida
DBC Research USA
Pembroke Pines, Florida
New Tampa Health
Tampa, Florida
James A Haley Veterans Hospital
Tampa, Florida
Cardiology Partners Clinical Research Institute
Wellington, Florida
Flourish Research
Winter Park, Florida
Morehouse School Of Medicine
Atlanta, Georgia
Atlanta Heart Specialists LLC
Tucker, Georgia
Synexus Clinical Research US Inc
Chicago, Illinois
Chicago Clinical Research Inst
Chicago, Illinois
Cardiovascular Associates Research
Covington, Louisiana
Omega Clinical Research
Metairie, Louisiana
CV Ins of the South
Opelousas, Louisiana
Monroe Research Llc
West Monroe, Louisiana
Southern Clin Research Clinic
Zachary, Louisiana
Showing 40 of 89 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.